Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects.

Wafik Nabih N, Nafie MS, Babker A, Alameen AAM, Fahmy SA

Open source

DOI
10.1039/d5nr03373j
Published
2025 Dec 11
Container
Nanoscale
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d5nr03373j,
  title = {Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects.},
  author = {Wafik Nabih N and Nafie MS and Babker A and Alameen AAM and Fahmy SA},
  year = {2025},
  journal = {Nanoscale},
  doi = {10.1039/d5nr03373j},
  url = {https://doi.org/10.1039/d5nr03373j}
}

RIS

TY  - JOUR
TI  - Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects.
AU  - Wafik Nabih N
AU  - Nafie MS
AU  - Babker A
AU  - Alameen AAM
AU  - Fahmy SA
PY  - 2025
JO  - Nanoscale
DO  - 10.1039/d5nr03373j
UR  - https://doi.org/10.1039/d5nr03373j
ER  - 

APA

N, W. N., MS, N., A, B., AAM, A., & SA, F. (2025). Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects.. Nanoscale. https://doi.org/10.1039/d5nr03373j

Source records